FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $1,641 | +64% |
| 3 years ago (2023) | $1,411 | +41% |
| 5 years ago (2021) | $1,303 | +30% |
| 10 years ago (2016) | $1,045 | +5% |
| since 1993 | $50,382 | +4938% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +15% | $1,148 (+15%) |
| 2025 | +43% | $1,641 (+64%) |
| 2024 | +10% | $1,805 (+81%) |
| 2023 | -22% | $1,411 (+41%) |
| 2022 | +9% | $1,544 (+54%) |
| 2021 | -16% | $1,303 (+30%) |
| 2020 | -0% | $1,298 (+30%) |
| 2019 | +37% | $1,783 (+78%) |
| 2018 | -33% | $1,197 (+20%) |
| 2017 | -6% | $1,131 (+13%) |
| 2016 | -8% | $1,045 (+5%) |
π See the analyst analysis of Incyte β
$1000 invested in Incyte 5 years ago would be worth $1,303 today, and $1,045 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: +10%. 2025: +43%. 2026: +15%. Full breakdown in the table above.
Over 10 years, Incyte's average annual return (CAGR) is about 0% per year, and 5%/yr over 5 years.
Best year: 2025 (+43%). Worst year: 2018 (-33%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Incyte is worth $1,303, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.